Gaingels

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Healthtech · Jan 1, 2026

Gaingels co-invests alongside venture leads in companies committed to diverse and inclusive teams, spanning seed through growth and pre-IPO rounds across technology, healthcare and consumer markets.

Its investor community includes LGBTQ+ people and allies, extending representation within the ownership of venture-backed companies. Portfolio companies work with its Gaingels Letter commitments and Venture Inclusion programme on building more inclusive organisations.

A board access programme provides free recruitment advice for diverse board members and observers. This gives founders a practical governance resource alongside a co-investment partner for a round led by another venture firm.

Sources
Rounds participated in
7
Confirmed lead rounds
0
5 roles undisclosed
New companies
7
First participation on record · 0 follow-on
Funding in participating rounds
$406M
6 disclosed · full round size, not this investor’s share

By stage

Undisclosed3
Series A2
Series B1
Series C+1

By primary sector

Healthtech4
Biotech3

By country

United States6
1

Rounds

7 in this selection
Tiny Health

Tiny Health provides gut and vaginal microbiome testing and analysis to help families understand microbiome health across life stages.

$33MSeries B
Participant
MoneyStack

MoneyStack provides financial counselling within behavioural-health programmes, helping people address money problems alongside treatment.

$1MUndisclosed
Participant
Kanvas Biosciences

Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy

$48MSeries A
Role not disclosed
Latus Bio, Inc.

Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2

$97MSeries A
Role not disclosed
Alloy Therapeutics

Drug discovery platforms and integrated development services for biotechnology and pharmaceutical partners.

$40MSeries E
Role not disclosed
Nitra

AI-native operating system for healthcare practices to automate back office functions

$187MSeries A+Series B+Debt
Role not disclosed